GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (HKSE:03933) » Definitions » ROA %

United Laboratories International Holdings (HKSE:03933) ROA % : 13.90% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. United Laboratories International Holdings's annualized Net Income for the quarter that ended in Dec. 2023 was HK$3,099 Mil. United Laboratories International Holdings's average Total Assets over the quarter that ended in Dec. 2023 was HK$22,306 Mil. Therefore, United Laboratories International Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was 13.90%.

The historical rank and industry rank for United Laboratories International Holdings's ROA % or its related term are showing as below:

HKSE:03933' s ROA % Range Over the Past 10 Years
Min: -1.78   Med: 4.43   Max: 13.47
Current: 13.47

During the past 13 years, United Laboratories International Holdings's highest ROA % was 13.47%. The lowest was -1.78%. And the median was 4.43%.

HKSE:03933's ROA % is ranked better than
91.04% of 1082 companies
in the Drug Manufacturers industry
Industry Median: 1.615 vs HKSE:03933: 13.47

United Laboratories International Holdings ROA % Historical Data

The historical data trend for United Laboratories International Holdings's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings ROA % Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.19 4.73 6.41 8.57 13.37

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.57 7.32 10.23 13.12 13.90

Competitive Comparison of United Laboratories International Holdings's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's ROA % distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's ROA % falls into.



United Laboratories International Holdings ROA % Calculation

United Laboratories International Holdings's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=2954.68/( (21194.827+22988.148)/ 2 )
=2954.68/22091.4875
=13.37 %

United Laboratories International Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=3099.45/( (21623.998+22988.148)/ 2 )
=3099.45/22306.073
=13.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


United Laboratories International Holdings  (HKSE:03933) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=3099.45/22306.073
=(Net Income / Revenue)*(Revenue / Total Assets)
=(3099.45 / 14948.358)*(14948.358 / 22306.073)
=Net Margin %*Asset Turnover
=20.73 %*0.6701
=13.90 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


United Laboratories International Holdings ROA % Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (HKSE:03933) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.
Executives
Heren Far East #4 Limited 2201 Interest of corporation controlled by you
Heren Far East Limited 2101 Beneficial owner
Iq Eq Services (hk) Limited 2201 Interest of corporation controlled by you

United Laboratories International Holdings (HKSE:03933) Headlines

No Headlines